ストックスクリーナーアプリを入手
66.81
0.58%
-0.2835
前日終値:
$67.09
開ける：
$66.85
24時間の取引高:
1.20M
Relative Volume:
0.13
時価総額：
$81.29B
収益：
$378.96B
当期純損益:
$5.28B
株価収益率:
15.94
EPS:
4.19
ネットキャッシュフロー:
$5.94B
1週間 パフォーマンス:
+1.49%
1か月 パフォーマンス:
+6.67%
6か月 パフォーマンス:
+47.31%
1年 パフォーマンス:
+9.33%
1日の値動き範囲:
$66.48
$66.98
1週間の範囲:
$64.82
$68.60
52週間の値動き範囲:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
CVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
66.71 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
310.50 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
374.80 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
314.70 | 83.78B | 254.47B | 5.03B | 6.01B | 18.06 |
|
HUM
Humana Inc
|
241.31 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | アップグレード | Edward Jones | Hold → Buy |
| 2024-12-03 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-10-04 | アップグレード | TD Cowen | Hold → Buy |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-05-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-05-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2023-12-22 | 開始されました | HSBC Securities | Buy |
| 2023-09-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-09-12 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-05-26 | 開始されました | Piper Sandler | Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Buy |
| 2022-05-27 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 開始されました | Goldman | Buy |
| 2021-12-01 | 開始されました | Seaport Research Partners | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2021-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-01-08 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-17 | 開始されました | Piper Sandler | Overweight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-06-05 | アップグレード | Standpoint Research | Hold → Buy |
| 2019-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-04-15 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-13 | 開始されました | Bernstein | Outperform |
| 2019-02-20 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-18 | 開始されました | Barclays | Overweight |
| 2018-11-29 | 再開されました | Goldman | Neutral |
| 2018-11-28 | 開始されました | Evercore ISI | Outperform |
| 2018-10-26 | 再開されました | Wolfe Research | Peer Perform |
| 2018-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-13 | 繰り返されました | Citigroup | Neutral |
すべてを表示
Cvs Health Corp (CVS) 最新ニュース
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025? - The Globe and Mail
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) - AOL.com
CVS Health (CVS) Faces Slight Dip After Recent Gains - GuruFocus
Wells Fargo Remains Bullish on CVS Health (CVS) With an $84 PT - Insider Monkey
Zacks Industry Outlook Highlights CVS Health, BrightSpring Health Services and GeneDx - Zacks Investment Research
Lesa Sroufe & Co Acquires Shares of 3,965 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Position Reduced by Birch Hill Investment Advisors LLC - MarketBeat
Brown Miller Wealth Management LLC Purchases Shares of 3,784 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Farmers & Merchants Investments Inc. - MarketBeat
15,438 Shares in CVS Health Co. (NYSE:CVS) Purchased by Krilogy Financial LLC - MarketBeat
HIV, AIDS Patients Denied Class Cert. In CVS Bias Fight - Law360
CVS Health stock rises after medicare PBM limits stripped from tax bill - Investing.com
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom - Yahoo Finance
North Star Investment Management Corp. Trims Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Fifth Third Bancorp Has $11.50 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Salem Investment Counselors Inc. Cuts Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
8,014 Shares in CVS Health Co. (NYSE:CVS) Acquired by Simon Quick Advisors LLC - MarketBeat
Mn Services Vermogensbeheer B.V. Sells 31,000 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Factory Mutual Insurance Co. Has $30.44 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Is the Artificial Intelligence Boost Fading for This Top Tech Stock? - The Motley Fool
CVS Health Co. (NYSE:CVS) Stock Holdings Trimmed by Coerente Capital Management - MarketBeat
Hennessy Advisors Inc. Grows Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health’s SWOT analysis: stock recovery potential amid sector challenges - Investing.com
Louisiana AG investigating CVS for sending mass text messages lobbying against legislation - Providence Business News
CVS Health Stock Sees Relative Strength Rating Rise To 78 - Investor's Business Daily
CVS Health blasts big pharma, praises Trump amid scrutiny of its own drug pricing practicesProvidence Business First - The Business Journals
CVS Wants To Halt Ark. Law Banning PBM-Owned Pharmacies - Law360
CVS Health Co. (NYSE:CVS) Stake Increased by Parkside Investments LLC - MarketBeat
Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis - Yahoo Finance
Avanza Fonder AB Has $6.22 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
KMG Fiduciary Partners LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Seeks Court-Ordered Pause on Embattled Arkansas Pharmacy Law - Bloomberg Law News
CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends? - Barchart.com
CVS Health Co. (NYSE:CVS) Shares Bought by Toth Financial Advisory Corp - MarketBeat
CVS Health Co. (NYSE:CVS) Director Purchases $100,009.00 in Stock - MarketBeat
Is CVS Health Stock Outperforming the Nasdaq? - MSN
CVS vs. DHR: Which Stock Should Value Investors Buy Now? - Yahoo Finance
SG Americas Securities LLC Acquires 174,606 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Feds seek $706 million in penalties from Omnicare, CVS in False Claims Act case - McKnight's Senior Living
CVS Health: Seems Primed To Withstand Industry Woes (NYSE:CVS) - Seeking Alpha
CVS Settles Cigna Lawsuit Over Ex-Executive’s Noncompete Pact - Bloomberg Law News
CVS retains some liability in Omnicare false claims suit, federal judge says - McKnight's Senior Living
CVS Health Co. (NYSE:CVS) Shares Sold by Wesbanco Bank Inc. - MarketBeat
Government Seeks $706M Penalty in FCA Case Against Omnicare and CVS Health - USA Herald
Naples Global Advisors LLC Lowers Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Cvs health director Guy Sansone acquires $100k in common stock - Investing.com Nigeria
Gov't Seeks $706M Penalty In FCA Case Against Omnicare, CVS - Law360
Is CVS Health Stock Outperforming The Nasdaq? - Barchart.com
Insider Buying: Guy Sansone Acquires Shares of CVS Health Corp - GuruFocus
Olstein Capital Management L.P. Decreases Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar? - MSN
Cvs Health Corp (CVS) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
0.04%
大文字化:
|
ボリューム (24 時間):